128 related articles for article (PubMed ID: 9949285)
1. Granulosa cell tumor of the ovary. Immunohistochemical evidence of low proliferative activity and virtual absence of mutation of the p53 tumor-suppressor gene.
Horny HP; Marx L; Kröber S; Lüttges J; Kaiserling E; Dietl J
Gynecol Obstet Invest; 1999; 47(2):133-8. PubMed ID: 9949285
[TBL] [Abstract][Full Text] [Related]
2. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
Costa MJ; Walls J; Ames P; Roth LM
Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
[TBL] [Abstract][Full Text] [Related]
3. Assessment of inhibin and p53 in granulosa cell tumors of the ovary.
Gebhart JB; Roche PC; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2000 May; 77(2):232-6. PubMed ID: 10785470
[TBL] [Abstract][Full Text] [Related]
4. Ovarian granulosa cell tumors with bizarre nuclei: an immunohistochemical analysis with fluorescence in situ hybridization documenting trisomy 12 in the bizarre component [corrected].
Gaffey MJ; Frierson HF; Iezzoni JC; Mills SE; Clement PB; Gersell DJ; Shashi V; von Kap-Herr C; Young RH
Mod Pathol; 1996 Mar; 9(3):308-15. PubMed ID: 8685233
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53, c-erbB-2, Ki-67, and CD34 in granulosa cell tumor of the ovary.
Kusamura S; Derchain S; Alvarenga M; Gomes CP; Syrjänen KJ; Andrade LA
Int J Gynecol Cancer; 2003; 13(4):450-7. PubMed ID: 12911721
[TBL] [Abstract][Full Text] [Related]
6. [The role of Ki-67, mutant suppressor gene p53 and low mitotic levels in defining the prognosis for adult granulosa cell tumor of the ovary].
Volkova AV; Chepik OF; Bakhidze EV; Ten VP
Vopr Onkol; 2005; 51(4):455-9. PubMed ID: 16308978
[TBL] [Abstract][Full Text] [Related]
7. Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation.
Le BH; Boyer PJ; Lewis JE; Kapadia SB
Arch Pathol Lab Med; 2004 Jul; 128(7):771-5. PubMed ID: 15214825
[TBL] [Abstract][Full Text] [Related]
8. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical comparison of p53, Ki-67, CD68, vimentin, α-smooth muscle actin and alpha-1-antichymotry-psin in oral peripheral and central giant cell granuloma.
Kujan O; Al-Shawaf AZ; Azzeghaiby S; AlManadille A; Aziz K; Raheel SA
J Contemp Dent Pract; 2015 Jan; 16(1):20-4. PubMed ID: 25876945
[TBL] [Abstract][Full Text] [Related]
10. Granulosa cell tumors of unilocular cystic type.
Mulvany NJ; Riley CB
Pathology; 1997 Nov; 29(4):348-53. PubMed ID: 9423213
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value.
Costa MJ; DeRose PB; Roth LM; Brescia RJ; Zaloudek CJ; Cohen C
Hum Pathol; 1994 Jan; 25(1):60-6. PubMed ID: 8314261
[TBL] [Abstract][Full Text] [Related]
12. Characteristic pattern of genetic aberrations in ovarian granulosa cell tumors.
Mayr D; Kaltz-Wittmer C; Arbogast S; Amann G; Aust DE; Diebold J
Mod Pathol; 2002 Sep; 15(9):951-7. PubMed ID: 12218213
[TBL] [Abstract][Full Text] [Related]
13. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors.
Jurić G; Zarković N; Nola M; Tillian M; Jukić S
Tumori; 2001; 87(1):47-53. PubMed ID: 11669558
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 is not a feature of ovarian granulosa cell tumors.
Liu FS; Ho ES; Lai CR; Chen JT; Shih RT; Yang CH; Tsao CM
Gynecol Oncol; 1996 Apr; 61(1):50-3. PubMed ID: 8626117
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
Domagala W; Markiewski M; Harezga B; Dukowicz A; Osborn M
Clin Cancer Res; 1996 Jan; 2(1):147-54. PubMed ID: 9816101
[TBL] [Abstract][Full Text] [Related]
17. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.
Sembritzki O; Hagel C; Lamszus K; Deppert W; Bohn W
Neuro Oncol; 2002 Jul; 4(3):171-8. PubMed ID: 12084347
[TBL] [Abstract][Full Text] [Related]
19. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG
Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome.
Amir G; Issakov J; Meller I; Sucher E; Peyser A; Cohen IJ; Yaniv I; Ben Arush MW; Tavori U; Kollender Y; Ron N; Peylan-Ramu N
Hum Pathol; 2002 Feb; 33(2):170-4. PubMed ID: 11957141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
